APA (7th ed.) Citation

AB, K., KT, S., L, A., H, L., EJ, G., T, Z., . . . FG, B. (2026). Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial. JAMA dermatology, 162(5), 469. https://doi.org/10.1001/jamadermatol.2026.0155

Chicago Style (17th ed.) Citation

AB, Kimball, et al. "Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial." JAMA Dermatology 162, no. 5 (2026): 469. https://doi.org/10.1001/jamadermatol.2026.0155.

MLA (9th ed.) Citation

AB, Kimball, et al. "Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial." JAMA Dermatology, vol. 162, no. 5, 2026, p. 469, https://doi.org/10.1001/jamadermatol.2026.0155.